Interprofessional and Inter-Organisational Collaboration in the COVID-19 Vaccination Programme: Lessons From North Central London.

Publication date: Jan 26, 2025

To discuss inter-organisational collaboration in the context of the successful COVID-19 vaccination programme in North Central London (NCL). An action research study in 2023-2024. Six action research cycles used mixed qualitative methods. Four findings are presented which illustrate inter-organisational collaboration across professional and organisational boundaries: working in the action research group, learning to work as an action research group, working collaboratively in new ways, working outside professional, occupational and organisational silos. These themes are discussed in relation to the literature on interprofessional and inter-organisational collaboration. The COVID-19 vaccination programme offered a way out of the pandemic. Between December 2020 and February 2022, 2. 8 M people were vaccinated by the NCL Vaccination team in an example of inter-organisational collaboration between science, health and community. Staff on the vaccination programme worked inter-organisationally in new ways to achieve this. In NCL several thousand local residents joined the NHS to work with healthcare professionals including nurses, nursing associates and students to deliver the programme in new ways which are illustrative of inter-organisational collaboration. No PPI within this study. The implications for the profession and for healthcare organisations of the findings are that, in contrast to traditional ways of working which have been entrenched in silos of professional knowledge and expertise, health professionals are able to work in new ways and find inter-organisational work satisfying. This has implications for patients as it has the potential to improve communication between very different organisations and as the vaccination programme shows, results in successful public health vaccination rates. This study set out to create a public resource for learning (for future pandemics or other works of national effort) to commemorate the collaborative efforts of the diverse vaccination workforce and volunteers involved in the programme. Participation in the COVID-19 vaccination programme had a profound effect on NHS clinical and professional staff, on partners across business and volunteer organisation in North Central London and on volunteers from the public in North Central London. Inter-organisation collaboration has been sustained after the delivery of the vaccination programme in North Central London; innovative ways of working have been introduced in the local community to deliver ongoing vaccinations and wider prevention activities and the partnership between academia and clinical practice. The research findings have had an impact on the research participants and the wider public through the website created as a public resource to commemorate the COVID-19 vaccination programme in North Central London. The consolidated criteria for reporting qualitative studies (COREQ) was used as a guide throughout data collection and analysis. The public were involved as participants in this study. They did not participate in the study design.

Open Access PDF

Concepts Keywords
Academia COVID‐19 vaccination programme
February inter‐organisational collaboration
Pandemics interprofessional collaboration
Vaccinated

Semantics

Type Source Name
disease MESH COVID-19
drug DRUGBANK Etoperidone
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction
disease MESH uncertainty
drug DRUGBANK Spinosad
disease MESH confusion
drug DRUGBANK L-Arginine
disease IDO history
disease MESH Polio
disease IDO production
drug DRUGBANK Trestolone
disease IDO process
disease MESH health inequalities
disease MESH emergency
drug DRUGBANK Polyethylene glycol
drug DRUGBANK Ranitidine
disease IDO site
drug DRUGBANK Methylergometrine
disease MESH anxiety
drug DRUGBANK Medical air
disease MESH morbidity
drug DRUGBANK L-Aspartic Acid
disease MESH privacy
drug DRUGBANK Alpha-1-proteinase inhibitor
drug DRUGBANK Pentaerythritol tetranitrate

Original Article

(Visited 1 times, 1 visits today)